Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar

Devendra Bansal, Praveen K. Bharti, Anushree Acharya, Mohamed H. Abdelraheem, Priyanka Patel, Ashraf Elmalik, Salem Abosalah, Fahmi Y. Khan, Mohamed ElKhalifa, Hargobinder Kaur, Elmoubasher Farag, Nilanju P. Sarmah, Pradyumna K. Mohapatra, Rakesh Sehgal, Jagadish Mahanta, Ali Sultan

Research output: Contribution to journalArticle

Abstract

Malaria remains a significant public health challenge and is of global importance. Imported malaria is a growing problem in non-endemic areas throughout the world and also in Qatar due to a massive influx of migrants from endemic countries. Antimalarial drug resistance is an important deterrent in our fight against malaria today. Molecular markers mirror intrinsic antimalarial drug resistance and their changes precede clinical resistance. Thus, in the present study, molecular markers of sulphadoxine-pyrimethamine (Pfdhfr and Pfdhps) and artemisinin (PfATPase6 and Pfk13) were sequenced to determine the drug resistance genotypes among 118 imported P. falciparum isolates in Qatar, between 2013 and 2016. All the isolates had mutant Pfdhfr alleles, with either double mutant (51I/108N) (59.3%) or triple mutant (51I, 59R and 108N) (30.6%) genotypes. I164L substitution was not found in this study. In case of Pfdhps, majority of the samples were carriers of either single (S436A/ A437G/ K540E) mutant (47.2%) or double (S436A/K540E, A437G/K540E, K540E/A581G) mutant (39.8%). A single novel point mutation (431V) was observed in the samples originated from Nigeria and Ghana. Polymorphisms in PfATPase6 were absent and only one non-synonymous mutation in Pfk13 was found at codon G453A from a sample of Kenyan origin. High levels of sulphadoxine-pyrimethamine resistance in the present study provide potential information about the spread of antimalarial drug resistance and will be beneficial for the treatment of imported malaria cases in Qatar.

Original languageEnglish
JournalPathogens and Global Health
DOIs
Publication statusPublished - 1 Jan 2019

Fingerprint

Qatar
Folic Acid Antagonists
Plasmodium falciparum
Drug Resistance
Malaria
Antimalarials
Genotype
Ghana
Nigeria
Point Mutation
Codon
Public Health
Alleles
Mutation
artemisinine

Keywords

  • artemisinin combination therapy
  • Imported malaria
  • molecular drug resistance
  • Qatar
  • sulphadoxine-pyrimethamine

ASJC Scopus subject areas

  • Parasitology
  • Microbiology
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar. / Bansal, Devendra; Bharti, Praveen K.; Acharya, Anushree; Abdelraheem, Mohamed H.; Patel, Priyanka; Elmalik, Ashraf; Abosalah, Salem; Khan, Fahmi Y.; ElKhalifa, Mohamed; Kaur, Hargobinder; Farag, Elmoubasher; Sarmah, Nilanju P.; Mohapatra, Pradyumna K.; Sehgal, Rakesh; Mahanta, Jagadish; Sultan, Ali.

In: Pathogens and Global Health, 01.01.2019.

Research output: Contribution to journalArticle

Bansal, D, Bharti, PK, Acharya, A, Abdelraheem, MH, Patel, P, Elmalik, A, Abosalah, S, Khan, FY, ElKhalifa, M, Kaur, H, Farag, E, Sarmah, NP, Mohapatra, PK, Sehgal, R, Mahanta, J & Sultan, A 2019, 'Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar', Pathogens and Global Health. https://doi.org/10.1080/20477724.2019.1639018
Bansal, Devendra ; Bharti, Praveen K. ; Acharya, Anushree ; Abdelraheem, Mohamed H. ; Patel, Priyanka ; Elmalik, Ashraf ; Abosalah, Salem ; Khan, Fahmi Y. ; ElKhalifa, Mohamed ; Kaur, Hargobinder ; Farag, Elmoubasher ; Sarmah, Nilanju P. ; Mohapatra, Pradyumna K. ; Sehgal, Rakesh ; Mahanta, Jagadish ; Sultan, Ali. / Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar. In: Pathogens and Global Health. 2019.
@article{ffed0e75f05d4eb790fd57ae215b2b53,
title = "Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar",
abstract = "Malaria remains a significant public health challenge and is of global importance. Imported malaria is a growing problem in non-endemic areas throughout the world and also in Qatar due to a massive influx of migrants from endemic countries. Antimalarial drug resistance is an important deterrent in our fight against malaria today. Molecular markers mirror intrinsic antimalarial drug resistance and their changes precede clinical resistance. Thus, in the present study, molecular markers of sulphadoxine-pyrimethamine (Pfdhfr and Pfdhps) and artemisinin (PfATPase6 and Pfk13) were sequenced to determine the drug resistance genotypes among 118 imported P. falciparum isolates in Qatar, between 2013 and 2016. All the isolates had mutant Pfdhfr alleles, with either double mutant (51I/108N) (59.3{\%}) or triple mutant (51I, 59R and 108N) (30.6{\%}) genotypes. I164L substitution was not found in this study. In case of Pfdhps, majority of the samples were carriers of either single (S436A/ A437G/ K540E) mutant (47.2{\%}) or double (S436A/K540E, A437G/K540E, K540E/A581G) mutant (39.8{\%}). A single novel point mutation (431V) was observed in the samples originated from Nigeria and Ghana. Polymorphisms in PfATPase6 were absent and only one non-synonymous mutation in Pfk13 was found at codon G453A from a sample of Kenyan origin. High levels of sulphadoxine-pyrimethamine resistance in the present study provide potential information about the spread of antimalarial drug resistance and will be beneficial for the treatment of imported malaria cases in Qatar.",
keywords = "artemisinin combination therapy, Imported malaria, molecular drug resistance, Qatar, sulphadoxine-pyrimethamine",
author = "Devendra Bansal and Bharti, {Praveen K.} and Anushree Acharya and Abdelraheem, {Mohamed H.} and Priyanka Patel and Ashraf Elmalik and Salem Abosalah and Khan, {Fahmi Y.} and Mohamed ElKhalifa and Hargobinder Kaur and Elmoubasher Farag and Sarmah, {Nilanju P.} and Mohapatra, {Pradyumna K.} and Rakesh Sehgal and Jagadish Mahanta and Ali Sultan",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/20477724.2019.1639018",
language = "English",
journal = "Pathogens and Global Health",
issn = "2047-7724",
publisher = "Maney Publishing",

}

TY - JOUR

T1 - Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar

AU - Bansal, Devendra

AU - Bharti, Praveen K.

AU - Acharya, Anushree

AU - Abdelraheem, Mohamed H.

AU - Patel, Priyanka

AU - Elmalik, Ashraf

AU - Abosalah, Salem

AU - Khan, Fahmi Y.

AU - ElKhalifa, Mohamed

AU - Kaur, Hargobinder

AU - Farag, Elmoubasher

AU - Sarmah, Nilanju P.

AU - Mohapatra, Pradyumna K.

AU - Sehgal, Rakesh

AU - Mahanta, Jagadish

AU - Sultan, Ali

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Malaria remains a significant public health challenge and is of global importance. Imported malaria is a growing problem in non-endemic areas throughout the world and also in Qatar due to a massive influx of migrants from endemic countries. Antimalarial drug resistance is an important deterrent in our fight against malaria today. Molecular markers mirror intrinsic antimalarial drug resistance and their changes precede clinical resistance. Thus, in the present study, molecular markers of sulphadoxine-pyrimethamine (Pfdhfr and Pfdhps) and artemisinin (PfATPase6 and Pfk13) were sequenced to determine the drug resistance genotypes among 118 imported P. falciparum isolates in Qatar, between 2013 and 2016. All the isolates had mutant Pfdhfr alleles, with either double mutant (51I/108N) (59.3%) or triple mutant (51I, 59R and 108N) (30.6%) genotypes. I164L substitution was not found in this study. In case of Pfdhps, majority of the samples were carriers of either single (S436A/ A437G/ K540E) mutant (47.2%) or double (S436A/K540E, A437G/K540E, K540E/A581G) mutant (39.8%). A single novel point mutation (431V) was observed in the samples originated from Nigeria and Ghana. Polymorphisms in PfATPase6 were absent and only one non-synonymous mutation in Pfk13 was found at codon G453A from a sample of Kenyan origin. High levels of sulphadoxine-pyrimethamine resistance in the present study provide potential information about the spread of antimalarial drug resistance and will be beneficial for the treatment of imported malaria cases in Qatar.

AB - Malaria remains a significant public health challenge and is of global importance. Imported malaria is a growing problem in non-endemic areas throughout the world and also in Qatar due to a massive influx of migrants from endemic countries. Antimalarial drug resistance is an important deterrent in our fight against malaria today. Molecular markers mirror intrinsic antimalarial drug resistance and their changes precede clinical resistance. Thus, in the present study, molecular markers of sulphadoxine-pyrimethamine (Pfdhfr and Pfdhps) and artemisinin (PfATPase6 and Pfk13) were sequenced to determine the drug resistance genotypes among 118 imported P. falciparum isolates in Qatar, between 2013 and 2016. All the isolates had mutant Pfdhfr alleles, with either double mutant (51I/108N) (59.3%) or triple mutant (51I, 59R and 108N) (30.6%) genotypes. I164L substitution was not found in this study. In case of Pfdhps, majority of the samples were carriers of either single (S436A/ A437G/ K540E) mutant (47.2%) or double (S436A/K540E, A437G/K540E, K540E/A581G) mutant (39.8%). A single novel point mutation (431V) was observed in the samples originated from Nigeria and Ghana. Polymorphisms in PfATPase6 were absent and only one non-synonymous mutation in Pfk13 was found at codon G453A from a sample of Kenyan origin. High levels of sulphadoxine-pyrimethamine resistance in the present study provide potential information about the spread of antimalarial drug resistance and will be beneficial for the treatment of imported malaria cases in Qatar.

KW - artemisinin combination therapy

KW - Imported malaria

KW - molecular drug resistance

KW - Qatar

KW - sulphadoxine-pyrimethamine

UR - http://www.scopus.com/inward/record.url?scp=85068855416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068855416&partnerID=8YFLogxK

U2 - 10.1080/20477724.2019.1639018

DO - 10.1080/20477724.2019.1639018

M3 - Article

JO - Pathogens and Global Health

JF - Pathogens and Global Health

SN - 2047-7724

ER -